Algert Global’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$301K Buy
72,026
+30,850
+75% +$148K ﹤0.01% 1020
2025
Q4
$198K Sell
41,176
-15,958
-28% -$77.2K ﹤0.01% 1063
2025
Q3
$289K Sell
57,134
-13,330
-19% -$58.9K ﹤0.01% 1004
2025
Q2
$284K Buy
70,464
+9,040
+15% +$29.4K 0.01% 1034
2025
Q1
$168K Sell
61,424
-6,820
-10% -$24.5K ﹤0.01% 1100
2024
Q4
$290K Buy
68,244
+35,120
+106% +$134K 0.01% 997
2024
Q3
$97K Buy
33,124
+6,070
+22% +$19.3K ﹤0.01% 1114
2024
Q2
$94K Sell
27,054
-7,784
-22% -$26K ﹤0.01% 1396
2024
Q1
$99K Buy
+34,838
New +$107K ﹤0.01% 1014

Other funds holding SRTA

Algert Global's SRTA Position: Q1 2026 in Review

Algert Global increased its Strata Critical Medical Inc (SRTA) stake by 75% in Q1 2026, buying an estimated $148K and bringing the position to 72,026 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #1020.

Algert Global first reported a position in SRTA in Q1 2024 and has held it in 9 quarters since. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Algert Global held 72,026 shares of Strata Critical Medical Inc worth $301K as of Q1 2026.
  • Algert Global bought 30,850 Strata Critical Medical Inc shares in Q1 2026, an estimated $148K.
  • Strata Critical Medical Inc made up ﹤0.01% of Algert Global's portfolio in Q1 2026, its #1020 holding.
  • Algert Global first reported a position in Strata Critical Medical Inc in Q1 2024 and has held it in 9 quarters since.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.